CorMedix, Inc. (CRMD) - Product Pipeline Analysis

CorMedix, Inc. (CRMD) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide24 Pages Price :
$ 750

CorMedix, Inc. (CorMedix) is a pharmaceutical company, based in the US. It develops and seeks to commercialize therapeutic products for the treatment of cardiac and renal dysfunction. The companys therapeutic candidates for cardiorenal disease may be little molecules, biologicals, devices and diagnostics that enable therapy. Its pipeline includes CRMD001, CRMD002, CRMD003 and CRMD004. The companys product CRMD001 is proprietary formulations of the oral iron chelator, deferiprone. It has rights to develop, manufacture and market its product CRMD001 worldwide. CorMedixs CRMD004 is a novel gel formulation in pre-clinical development. The company was founded in the year 2006. CorMedix is headquartered in Bridgewater, New Jersey, the US.

This report is a source for data, analysis and actionable intelligence on the CorMedix, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Key Facts 4
CorMedix, Inc. - Major Products and Services 5
CorMedix, Inc. Pipeline Products by Equipment Type 6
CorMedix, Inc. Pipeline Products by Development Stage 8
CorMedix, Inc. Pipeline Products by Therapy Area 10
CorMedix, Inc. Pipeline Products by Milestone Summary 12
Neutrolin 14
Neutrolin Product Status 14
Neutrolin Product Description 14
Neutrolin Product Milestone 14
Thixotropic Gel 15
Thixotropic Gel Product Status 15
Thixotropic Gel Product Description 15
Urine Labile Iron Test 16
Urine Labile Iron Test Product Status 16
Urine Labile Iron Test Product Description 16
CorMedix, Inc. - Key Competitors 17
CorMedix, Inc. - Key Employees 18
CorMedix, Inc. - Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
CorMedix, Inc., Recent Developments 20
Jul 02, 2012: CorMedix Announces Extension Of NYSE Amex Listing 20
May 15, 2012: CorMedix Reports Q1 2012 Results 20
May 03, 2012: CorMedix Appoints Randy Milby As COO 20
Apr 24, 2012: CorMedix Receives NYSE Amex Notice Of Delisting For Non-Compliance 20
Mar 19, 2012: CorMedix Reports 2011 Results 21
Nov 28, 2011: CorMedix Appoints Matthew Duffy To Board 21
Nov 10, 2011: CorMedix Reports Q3 2011 Results 21
Aug 12, 2011: CorMedix Appoints Steven Lefkowitz To Board 22
Aug 09, 2011: CorMedix Reports Q2 2011 Results 22
May 10, 2011: CorMedix Reports Net Loss Of $1.9m For Q1 2011 23

Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Table


CorMedix, Inc., Key Facts 1
CorMedix, Inc. Key Pipeline Products by Equipment Type 1
CorMedix, Inc. Key Pipeline Products by Therapy Area 1
CorMedix, Inc. Key Pipeline Products by Development Stage 1
CorMedix, Inc., Key Facts 4
CorMedix, Inc., Major Products and Services 5
CorMedix, Inc. Number of Pipeline Products by Equipment Type 6
CorMedix, Inc. Pipeline Products by Equipment Type 7
CorMedix, Inc. Number of Pipeline Products by Development Stage 8
CorMedix, Inc. Pipeline Products by Development Stage 9
CorMedix, Inc. Number of Pipeline Products by Therapy Area 10
CorMedix, Inc. Pipeline Products by Therapy Area 11
CorMedix, Inc. Number of Pipeline Products By Milestone Summary 12
CorMedix, Inc. Pipeline Products by Milestone Summary 13
Neutrolin - Product Status 14
Neutrolin - Product Description 14
Neutrolin - Product Milestone 14
Thixotropic Gel - Product Status 15
Thixotropic Gel - Product Description 15
Urine Labile Iron Test - Product Status 16
Urine Labile Iron Test - Product Description 16
CorMedix, Inc., Key Employees 18

List of Chart


CorMedix, Inc. Key Pipeline Products by Equipment Type 1
CorMedix, Inc. Pipeline Products by Equipment Type 6
CorMedix, Inc. Pipeline Products by Development Stage 8
CorMedix, Inc. Pipeline Products by Therapy Area 10
CorMedix, Inc. Pipeline Products by Milestone Summary 12

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top